新闻BenzingaInvivyd And SPEAR Study Group Initiate FLINTLOCK Phase 2 Trial Evaluating Safety, Tolerability, Pharmacokinetics, And Clinical Efficacy Of High-Dose Monoclonal Antibody VYD2311 In Individuals With Long COVID Or Post-Vaccination Syndrome Invivyd And SPEAR Study Group Initiate FLINTLOCK Phase 2 Trial Evaluating Safety, Tolerability, Pharmacokinetics, And Clinical Efficacy Of High-Dose Monoclonal Antibody VYD2311 In Individuals With Long COVID Or Post-Vaccination Syndrome Benzinga 2026.10.14 11:05 (GMT+0) 在Benzinga上打开 其他新闻 欧洲顶级运营商探索卫星集团以抵御 SpaceX——彭博社 HC Wainwright & Co. 重申对 Zentalis Pharmaceuticals 的“买入”评级，维持 10 美元目标价 据报道，10月16日，“据消息人士称，CFP已与ESPN就播出24队季后赛达成‘握手协议’”——ESPN HC Wainwright & Co.维持对 Enliven Therapeutics 的“买入”评级，将目标价上调至 73 美元 Needham重申对Harmony Biosciences Hldgs的“买入”评级，维持50美元目标价 AI热潮撞上电力瓶颈：微软退出Nscale在英国的数据中心交易
